Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis
Authors
Keywords
-
Journal
World Psychiatry
Volume 15, Issue 3, Pages 195-204
Publisher
Wiley
Online
2016-09-22
DOI
10.1002/wps.20341
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabis and Psychosis: What Degree of Proof Do We Require?
- (2016) Robin M. Murray et al. BIOLOGICAL PSYCHIATRY
- Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis
- (2016) Liana Fattore BIOLOGICAL PSYCHIATRY
- Association Between Cannabis and Psychosis: Epidemiologic Evidence
- (2016) Suzanne H. Gage et al. BIOLOGICAL PSYCHIATRY
- Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States
- (2016) Mahmoud A. ElSohly et al. BIOLOGICAL PSYCHIATRY
- The association between cannabis use and anxiety disorders: Results from a population-based representative sample
- (2016) Daniel Feingold et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
- (2016) F Patti et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
- (2016) C Mokrysz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies
- (2016) Nicholas J. Jackson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
- (2016) Arianna Marconi et al. SCHIZOPHRENIA BULLETIN
- Cannabis-induced psychosis associated with high potency “wax dabs”
- (2016) Joseph M. Pierre et al. SCHIZOPHRENIA RESEARCH
- Cannabis and Psychosis: a Critical Overview of the Relationship
- (2016) Charles Ksir et al. Current Psychiatry Reports
- Long-term Marijuana Use and Cognitive Impairment in Middle Age
- (2016) Wayne Hall et al. JAMA Internal Medicine
- Association Between Lifetime Marijuana Use and Cognitive Function in Middle Age
- (2016) Reto Auer et al. JAMA Internal Medicine
- Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
- (2016) Nora D. Volkow et al. JAMA Psychiatry
- Cannabis Use and Risk of Psychiatric Disorders
- (2016) Carlos Blanco et al. JAMA Psychiatry
- AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers
- (2016) C J A Morgan et al. Translational Psychiatry
- Hippocampal harms, protection and recovery following regular cannabis use
- (2016) M Yücel et al. Translational Psychiatry
- Adolescent cannabis and tobacco use and educational outcomes at age 16: birth cohort study
- (2015) Alexander I. Stiby et al. ADDICTION
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
- (2015) Robert J. Tait et al. CLINICAL TOXICOLOGY
- Associations of adolescent cannabis use with academic performance and mental health: A longitudinal study of upper middle class youth
- (2015) Madeline H. Meier et al. DRUG AND ALCOHOL DEPENDENCE
- Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
- (2015) Craig A. Press et al. EPILEPSY & BEHAVIOR
- Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
- (2015) Chandni Hindocha et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The association between cannabis use and mood disorders: A longitudinal study
- (2015) Daniel Feingold et al. JOURNAL OF AFFECTIVE DISORDERS
- Daily Marijuana Use Is Not Associated with Brain Morphometric Measures in Adolescents or Adults
- (2015) B. J. Weiland et al. JOURNAL OF NEUROSCIENCE
- Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data
- (2015) Michael H. Andreae et al. JOURNAL OF PAIN
- Genetic moderation of the effects of cannabis: Catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences
- (2015) Elizabeth M Tunbridge et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample
- (2015) Adam Winstock et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Perspective: Be clear about the real risks
- (2015) Matthew Hill NATURE
- Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed
- (2015) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoids in the Treatment of Epilepsy
- (2015) Daniel Friedman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differences in cannabis-related experiences between patients with a first episode of psychosis and controls
- (2015) F. Bianconi et al. PSYCHOLOGICAL MEDICINE
- Effect of high-potency cannabis on corpus callosum microstructure
- (2015) S. Rigucci et al. PSYCHOLOGICAL MEDICINE
- Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
- (2015) T. P. Freeman et al. PSYCHOLOGICAL MEDICINE
- The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis
- (2015) T. Schoeler et al. PSYCHOLOGICAL MEDICINE
- Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
- (2015) Matthijs G. Bossong et al. PSYCHOPHARMACOLOGY
- Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis
- (2015) Marco Colizzi et al. SCHIZOPHRENIA BULLETIN
- Long-term risk factors for substance-induced and primary psychosis after release from prison. A longitudinal study of substance users
- (2015) Eline Borger Rognli et al. SCHIZOPHRENIA RESEARCH
- Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis
- (2015) Chelsea Arnold et al. SCHIZOPHRENIA RESEARCH
- Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study
- (2015) David M. Fergusson et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study
- (2015) Nanna Gilliam Toftdahl et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Novel psychoactive substances of interest for psychiatry
- (2015) Fabrizio Schifano et al. World Psychiatry
- Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence
- (2015) Leon French et al. JAMA Psychiatry
- Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure
- (2015) David Pagliaccio et al. JAMA Psychiatry
- Cannabis Liberalization and Adolescent Cannabis Use: A Cross-National Study in 38 Countries
- (2015) Yuyan Shi et al. PLoS One
- What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?
- (2014) Wayne Hall ADDICTION
- Different Dopaminergic Abnormalities Underlie Cannabis Dependence and Cannabis-Induced Psychosis
- (2014) Robin M. Murray et al. BIOLOGICAL PSYCHIATRY
- A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies
- (2014) Karina Karolina Kedzior et al. BMC Psychiatry
- Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
- (2014) Marisol S. Castaneto et al. DRUG AND ALCOHOL DEPENDENCE
- Genetic predisposition to schizophrenia associated with increased use of cannabis
- (2014) R A Power et al. MOLECULAR PSYCHIATRY
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity
- (2014) N. D. Volkow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children
- (2014) S. H. Gage et al. PSYCHOLOGICAL MEDICINE
- How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆ 9 -Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia
- (2014) Daniel Freeman et al. SCHIZOPHRENIA BULLETIN
- Cannabis abuse and age at onset in schizophrenia patients with large, rare copy number variants
- (2014) Andrew Kenneth Martin et al. SCHIZOPHRENIA RESEARCH
- Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond
- (2013) Robin Room ADDICTION
- Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms
- (2013) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- A review of the cultivation and processing of cannabis (Cannabis sativaL.) for production of prescription medicines in the UK
- (2013) David J. Potter Drug Testing and Analysis
- Reasons for cannabis use among youths at ultra high risk for psychosis
- (2013) Kelly E. Gill et al. Early Intervention in Psychiatry
- Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
- (2013) Brenda E. Porter et al. EPILEPSY & BEHAVIOR
- “Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report
- (2013) Duccio Papanti et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
- (2013) Wendy Swift et al. PLoS One
- Spicing things up: synthetic cannabinoids
- (2013) Max Spaderna et al. PSYCHOPHARMACOLOGY
- Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users
- (2013) M. Di Forti et al. SCHIZOPHRENIA BULLETIN
- Cannabis users have higher premorbid IQ than other patients with first onset psychosis
- (2013) Laura Ferraro et al. SCHIZOPHRENIA RESEARCH
- Multiple Functions of Endocannabinoid Signaling in the Brain
- (2012) István Katona et al. Annual Review of Neuroscience
- The Endocannabinoid System and the Brain
- (2012) Raphael Mechoulam et al. Annual Review of Psychology
- Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users
- (2012) Marta Di Forti et al. BIOLOGICAL PSYCHIATRY
- Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts
- (2012) Edison Manrique-Garcia et al. BMC Psychiatry
- Neurological Soft Signs in Patients with Psychosis and Cannabis Abuse: A Systematic Review and Meta-Analysis of Paradox
- (2012) Miguel Ruiz-Veguilla et al. CURRENT PHARMACEUTICAL DESIGN
- Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis.
- (2012) Amy M. Schreiner et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems
- (2012) Nathalie Ginovart et al. NEUROPSYCHOPHARMACOLOGY
- Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ9-THC in Humans
- (2012) Deepak Cyril D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Persistent cannabis users show neuropsychological decline from childhood to midlife
- (2012) M. H. Meier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids
- (2012) Kathryn A. Seely et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years
- (2011) Wulf Rössler et al. ADDICTION
- Cannabis Use and Earlier Onset of Psychosis
- (2011) Matthew Large et al. ARCHIVES OF GENERAL PSYCHIATRY
- AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
- (2011) Ruud van Winkel et al. NEUROPSYCHOPHARMACOLOGY
- Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
- (2011) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort
- (2011) E. Manrique-Garcia et al. PSYCHOLOGICAL MEDICINE
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
- (2010) Catalina Lopez-Quintero et al. DRUG AND ALCOHOL DEPENDENCE
- Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms
- (2010) Paul D Morrison et al. NEUROPSYCHOPHARMACOLOGY
- Cannabis with high Δ9-THC contents affects perception and visual selective attention acutely: An event-related potential study
- (2010) K.B.E. Böcker et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Neurophysiological and cognitive effects of smoked marijuana in frequent users
- (2010) Carl L. Hart et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- High-potency cannabis and the risk of psychosis
- (2009) Marta Di Forti et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabis and anxiety: a critical review of the evidence
- (2009) José Alexandre Crippa et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
- (2009) P. D. Morrison et al. PSYCHOLOGICAL MEDICINE
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabis use and adult ADHD symptoms
- (2008) David M. Fergusson et al. DRUG AND ALCOHOL DEPENDENCE
- Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids
- (2008) Lumír Ondřej Hanuš MEDICINAL RESEARCH REVIEWS
- Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis
- (2008) Deepak Cyril D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now